Sartorius Stedim Biotech S.A

(PINK:SDMHF)

Latest On Sartorius Stedim Biotech S.A (SDMHF):

Date/Time Type Description Signal Details
2021-03-29 06:01 ESTDividendA dividend of $0.68 has been announced on Feb 12, 2021. It will be paid Mar 31, 2021 with an ex-dividend date of Mar 29, 2021.Neutral
2021-03-18 09:36 ESTNewsSartorius Stedim Biotech raises FY2021 expectation on strong order intakeN/A
2021-02-21 09:14 ESTFinancialsCompany financials have been released.Neutral
2021-01-06 13:50 ESTNewsSartorius Stedim Biotech to buy Novasep's chromatography process equipment divisionN/A
2020-11-26 22:45 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 01:47 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 18:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-02 05:24 ESTFinancialsCompany financials have been released.Neutral
2020-10-20 09:46 ESTNewsSartorius Stedim Biotech S.A. reports 9M results, raised FY2020 outlookN/A
2020-09-26 15:03 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 07:09 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 11:04 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 14:40 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 10:24 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 18:48 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 06:47 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 22:59 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 06:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 14:40 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 19:27 ESTFinancialsCompany financials have been released.Neutral
2020-07-22 08:29 ESTNewsSartorius Stedim Biotech S.A. 2020 Q2 - Results - Earnings Call PresentationN/A
2020-07-21 05:12 ESTNewsSartorius Stedim Biotech S.A. reports 1H resultsN/A
2020-07-09 10:53 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 18:37 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 02:23 ESTFinancialsCompany financials have been released.Neutral
2020-06-29 06:00 ESTDividendA dividend of $0.34 has been announced on Feb 14, 2020. It will be paid Jul 1, 2020 with an ex-dividend date of Jun 29, 2020.Neutral
2020-06-19 14:30 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 06:36 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 08:12 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 07:13 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 02:47 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 07:27 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 18:24 ESTFinancialsCompany financials have been released.Neutral
2020-04-26 10:06 ESTFinancialsCompany financials have been released.Neutral
2020-04-26 02:39 ESTNewsSartorius Stedim Biotech S.A. reports Q1 resultsN/A
2020-04-20 06:13 ESTFinancialsCompany financials have been released.Neutral
2020-04-09 22:18 ESTFinancialsCompany financials have been released.Neutral
2020-04-09 06:15 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 22:47 ESTFinancialsCompany financials have been released.Neutral
2020-03-27 06:04 ESTDividendA dividend of $0.68 has been announced on Feb 14, 2020. It will be paid Mar 31, 2020 with an ex-dividend date of Mar 27, 2020.Neutral
2020-03-25 22:19 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 05:52 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 23:56 ESTFinancialsCompany financials have been released.Neutral
2020-02-22 01:29 ESTFinancialsCompany financials have been released.Neutral
2020-02-21 00:58 ESTFinancialsCompany financials have been released.Neutral
2020-02-18 01:15 ESTFinancialsCompany financials have been released.Neutral
2020-02-13 01:29 ESTFinancialsCompany financials have been released.Neutral
2020-02-10 11:34 ESTStock SplitA stock split has occured on May 6, 2016 with a split factor of 6:1.Neutral

About Sartorius Stedim Biotech S.A (SDMHF):

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

See Advanced Chart

General

  • Name Sartorius Stedim Biotech S.A
  • Symbol SDMHF
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • Full Time Employees 7,566
  • Last Split Factor6:1
  • Last Split Date2016-05-06
  • Fiscal Year EndDecember
  • Web URLhttp://www.sartorius.com
View More

Valuation

  • Trailing PE 169.22
  • Forward PE 60.24
  • Price/Sales (Trailing 12 Mt.) 16.02
  • Price/Book (Most Recent Quarter) 20.96
  • Enterprise Value Revenue 19.73
  • Enterprise Value EBITDA 63.7
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin 19%
  • Return on Assets 13%
  • Return on Equity 27%
  • Earnings Per Share $2.34
  • Revenue Per Share $0
  • Gross Profit 1 billion
  • Quarterly Earnings Growth 45.8%
View More

ESG Rating

  • Rating Date 2019-01-01
  • ESG Score 20.97
  • Environment Score 6.34
  • Social Score 12.94
  • Governance Score 9.18
  • Controversy Level 0
View More

Highlights

  • Market Capitalization 37.08 billion
  • PEG Ratio 3.94
  • Book Value Per Share $12.32
View More

Share Statistics

  • Shares Outstanding 92.18 million
  • Shares Float 24.14 million
  • % Held by Insiders 7430%
  • % Held by Institutions 11.3%
View More

Technicals

  • Beta 0.03
  • 52 Week High $499
  • 52 Week Low $174.44
  • 50 Day Moving Average 438.54
  • 200 Day Moving Average 380.12
View More

Dividends

  • Forward Annual Dividend Rate $0.38
  • Forward Annual Dividend Yield 0.1%
  • Payout Ratio 21%
  • Dividend Date N/A
  • ExDividend Date 2020-06-29
  • Dividend Per Share $0.54
  • Dividend Yield 0%
View More

Sartorius Stedim Biotech S.A (SDMHF) Dividend Calendar:

Sartorius Stedim Biotech S.A pays out 21% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Sartorius Stedim Biotech S.A (SDMHF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

SDMHF's next estimated earnings release date is June 30, 2021.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$N/A$1.48
2020-09-302020-12-31$N/A$1.52$0.9559.59%
2020-06-302020-09-30$N/A$1.29$0.9043.32%
2020-03-312020-06-30$N/A$0.82$0.767.93%
2019-12-312020-03-31$363.87 million$0.89$0.7027.53%
2019-09-302019-12-31$367.4 million$0.66$0.69-4.04%
2019-06-302019-09-30$366.4 million$0.69$0.672.49%
2019-03-312019-06-30$342.9 million$0.80$0.6130.49%
2018-12-312019-03-31$316.05 million$0.68$0.5915.97%
2018-09-302018-12-31$310.4 million$0.85$0.5943.41%
2018-06-302018-09-30$304.6 million$0.63$0.5416.09%
2018-03-312018-06-30$281.1 million$0.63$0.5318.96%
2017-12-312018-03-31$274.53 million$0.54$0.524.23%
2017-09-302017-12-31$259.7 million$0.57$0.4916.94%
2017-06-302017-09-30$277.9 million$0.48$0.51-4.98%
2017-03-312017-06-30$268.8 million$0.48
2016-12-312017-03-31$266.51 million$0.46$0.4111.9%
2016-09-302016-12-31$0.39$0.54-28.28%
2016-06-302016-09-30$0.53
2016-03-312016-06-30$0.48
2015-12-312016-03-31$0.45
2015-09-302015-12-31$0.29
2015-06-302015-09-30$0.50
2015-03-312015-06-30$0.39
2014-12-312015-03-31$0.22
2014-09-302014-12-31$0.24
2014-06-302014-09-30$0.27
2014-03-312014-06-30$0.29$0.00
2013-12-312014-03-31$0.23$0.00
2013-09-302013-12-31$0.25$0.00
2013-06-302013-09-30$0.22$0.00
2013-03-312013-06-30$0.29$0.00
2012-12-312013-03-31$0.19$0.00
2012-09-302012-12-31$0.20$0.00
2012-06-302012-09-30$0.23$0.00
2012-03-312012-06-30$0.16$0.00
2011-12-312012-03-31$0.20$0.00
2011-09-302011-12-31$0.15$0.00
2011-06-302011-09-30$0.18$0.00
2011-03-312011-06-30$0.15$0.00
2010-12-312011-03-31$0.17$0.00
2010-09-302010-12-31$0.17$0.00

Sartorius Stedim Biotech S.A (SDMHF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Sartorius Stedim Biotech S.A (SDMHF) Chart:

Sartorius Stedim Biotech S.A (SDMHF) News:

Below you will find a list of latest news for Sartorius Stedim Biotech S.A (SDMHF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Sartorius Stedim Biotech S.A (SDMHF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Sartorius Stedim Biotech S.A (SDMHF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link